vs
Side-by-side financial comparison of Solowin Holdings, Ltd. (AXG) and Cardiff Oncology, Inc. (CRDF). Click either name above to swap in a different company.
Solowin Holdings, Ltd. is the larger business by last-quarter revenue ($410.0K vs $243.0K, roughly 1.7× Cardiff Oncology, Inc.).
AXG vs CRDF — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $410.0K | $243.0K |
| Net Profit | — | $-7.2M |
| Gross Margin | — | — |
| Operating Margin | -34.1% | -3221.0% |
| Net Margin | — | -2969.5% |
| Revenue YoY | — | 62.0% |
| Net Profit YoY | — | 38.8% |
| EPS (diluted) | — | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $243.0K | ||
| Q3 25 | — | $120.0K | ||
| Q2 25 | — | $121.0K | ||
| Q1 25 | — | $109.0K | ||
| Q4 24 | — | $150.0K | ||
| Q3 24 | $410.0K | $165.0K | ||
| Q2 24 | — | $163.0K | ||
| Q1 24 | — | $205.0K |
| Q4 25 | — | $-7.2M | ||
| Q3 25 | — | $-11.3M | ||
| Q2 25 | — | $-13.9M | ||
| Q1 25 | — | $-13.4M | ||
| Q4 24 | — | $-11.8M | ||
| Q3 24 | — | $-11.9M | ||
| Q2 24 | — | $-11.8M | ||
| Q1 24 | — | $-10.0M |
| Q4 25 | — | -3221.0% | ||
| Q3 25 | — | -9978.3% | ||
| Q2 25 | — | -12212.4% | ||
| Q1 25 | — | -13194.5% | ||
| Q4 24 | — | -8381.3% | ||
| Q3 24 | -34.1% | -7637.0% | ||
| Q2 24 | — | -7696.3% | ||
| Q1 24 | — | -5333.2% |
| Q4 25 | — | -2969.5% | ||
| Q3 25 | — | -9381.7% | ||
| Q2 25 | — | -11523.1% | ||
| Q1 25 | — | -12324.8% | ||
| Q4 24 | — | -7858.0% | ||
| Q3 24 | — | -7184.8% | ||
| Q2 24 | — | -7225.8% | ||
| Q1 24 | — | -4883.4% |
| Q4 25 | — | $-0.11 | ||
| Q3 25 | — | $-0.17 | ||
| Q2 25 | — | $-0.21 | ||
| Q1 25 | — | $-0.20 | ||
| Q4 24 | — | $-0.22 | ||
| Q3 24 | — | $-0.25 | ||
| Q2 24 | — | $-0.26 | ||
| Q1 24 | — | $-0.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.5M | $58.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $6.0M | $45.4M |
| Total Assets | $13.1M | $61.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $58.3M | ||
| Q3 25 | — | $60.6M | ||
| Q2 25 | — | $71.0M | ||
| Q1 25 | — | $79.9M | ||
| Q4 24 | — | $91.7M | ||
| Q3 24 | $2.5M | $57.7M | ||
| Q2 24 | — | $60.3M | ||
| Q1 24 | — | $67.2M |
| Q4 25 | — | $45.4M | ||
| Q3 25 | — | $48.8M | ||
| Q2 25 | — | $58.6M | ||
| Q1 25 | — | $70.9M | ||
| Q4 24 | — | $82.9M | ||
| Q3 24 | $6.0M | $49.4M | ||
| Q2 24 | — | $52.4M | ||
| Q1 24 | — | $60.9M |
| Q4 25 | — | $61.9M | ||
| Q3 25 | — | $63.8M | ||
| Q2 25 | — | $75.7M | ||
| Q1 25 | — | $84.8M | ||
| Q4 24 | — | $97.2M | ||
| Q3 24 | $13.1M | $62.9M | ||
| Q2 24 | — | $66.1M | ||
| Q1 24 | — | $74.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.6M | $-6.0M |
| Free Cash FlowOCF − Capex | $-1.6M | — |
| FCF MarginFCF / Revenue | -392.9% | — |
| Capex IntensityCapex / Revenue | 4.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-6.0M | ||
| Q3 25 | — | $-10.8M | ||
| Q2 25 | — | $-8.3M | ||
| Q1 25 | — | $-12.8M | ||
| Q4 24 | — | $-10.3M | ||
| Q3 24 | $-1.6M | $-10.5M | ||
| Q2 24 | — | $-9.2M | ||
| Q1 24 | — | $-7.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-10.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.6M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-7.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | -9043.3% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -392.9% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -3814.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | 15.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | 4.4% | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 39.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
